FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2780234080> ?p ?o ?g. }

• W2780234080 endingPage "803" @default.
• W2780234080 startingPage "797" @default.
• W2780234080 abstract "AIMS AND BACKGROUND: Squamous cell carcinoma (SCC) is one of the most common skin cancers. Photodynamic therapy (PDT) is a non-invasive treatment for SCC, but it is usually effective only on tumors just under the skin. Resveratrol (Res) is a polyphenolic compound, which is capable of promoting apop tosis of a variety of cancer cells. Res administration is non-invasive and effective on SCC, thus it may be used as an adjuvant for PDT. So far, there is no published study investigating the combination use of PDT with Res to improve clinical outcome of SCC. So in this study, we will examine the effectiveness of combined treatment of PDT and Res as well as its underlying mechanism. METHODS: The human HaCaT keratinocytes and human A431 epidermoid carcinoma cells were treated with ALA-PDT or/and Res, and cell proliferation and apoptosis were evaluated by MTT and flow cytometry respectively afterwards. p-ERK, p38, p53 and caspase-3 protein expression was examined by western blot. Then a p38 inhibitor was added to test the involvement of p38 pathway in A431 cells responding to ALA-PDT and Res treatments. RESULTS: The results showed that Res could enhance the effect of ALA-PDT on cell proliferation and apoptosis in A431 cells. We also found that the expression of p-ERK, p-p38, p53 and caspase-3 was increased. However, inhibition of p38 pathway attenuated the effect of Res. CONCLUSION: Our study demonstrated that Res could enhance the effect of ALA-PDT against skin cancer cells through p38/ MAPK pathway." @default.
• W2780234080 created "2018-01-05" @default.
• W2780234080 creator A5006651636 @default.
• W2780234080 creator A5034266315 @default.
• W2780234080 creator A5049609799 @default.
• W2780234080 creator A5083572935 @default.
• W2780234080 creator A5085596479 @default.
• W2780234080 date "2018-03-14" @default.
• W2780234080 modified "2023-09-27" @default.
• W2780234080 title "Resveratrol enhances the effects of ALA-PDT on skin squamous cells A431 through p38/ MAPK signaling pathway" @default.
• W2780234080 cites W1562137689 @default.
• W2780234080 cites W1891730410 @default.
• W2780234080 cites W1899126153 @default.
• W2780234080 cites W1951847877 @default.
• W2780234080 cites W1952698752 @default.
• W2780234080 cites W1972946006 @default.
• W2780234080 cites W1990037409 @default.
• W2780234080 cites W1992899000 @default.
• W2780234080 cites W1995947422 @default.
• W2780234080 cites W1998298282 @default.
• W2780234080 cites W2050847362 @default.
• W2780234080 cites W2069451956 @default.
• W2780234080 cites W2084077080 @default.
• W2780234080 cites W2088528803 @default.
• W2780234080 cites W2119898601 @default.
• W2780234080 cites W2137726860 @default.
• W2780234080 cites W2150585579 @default.
• W2780234080 cites W2151089147 @default.
• W2780234080 cites W2160135312 @default.
• W2780234080 cites W2166312912 @default.
• W2780234080 cites W2293461885 @default.
• W2780234080 cites W2528209295 @default.
• W2780234080 cites W2765586819 @default.
• W2780234080 cites W2765727853 @default.
• W2780234080 cites W2766759318 @default.
• W2780234080 cites W2767167306 @default.
• W2780234080 doi "https://doi.org/10.3233/cbm-170495" @default.
• W2780234080 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29286920" @default.
• W2780234080 hasPublicationYear "2018" @default.
• W2780234080 type Work @default.
• W2780234080 sameAs 2780234080 @default.
• W2780234080 citedByCount "14" @default.
• W2780234080 countsByYear W27802340802019 @default.
• W2780234080 countsByYear W27802340802020 @default.
• W2780234080 countsByYear W27802340802021 @default.
• W2780234080 countsByYear W27802340802022 @default.
• W2780234080 countsByYear W27802340802023 @default.
• W2780234080 crossrefType "journal-article" @default.
• W2780234080 hasAuthorship W2780234080A5006651636 @default.
• W2780234080 hasAuthorship W2780234080A5034266315 @default.
• W2780234080 hasAuthorship W2780234080A5049609799 @default.
• W2780234080 hasAuthorship W2780234080A5083572935 @default.
• W2780234080 hasAuthorship W2780234080A5085596479 @default.
• W2780234080 hasConcept C104317684 @default.
• W2780234080 hasConcept C118995209 @default.
• W2780234080 hasConcept C121608353 @default.
• W2780234080 hasConcept C126322002 @default.
• W2780234080 hasConcept C1491633281 @default.
• W2780234080 hasConcept C153911025 @default.
• W2780234080 hasConcept C178790620 @default.
• W2780234080 hasConcept C185592680 @default.
• W2780234080 hasConcept C190283241 @default.
• W2780234080 hasConcept C2776415932 @default.
• W2780234080 hasConcept C2776816829 @default.
• W2780234080 hasConcept C2780783641 @default.
• W2780234080 hasConcept C2781018059 @default.
• W2780234080 hasConcept C2781323092 @default.
• W2780234080 hasConcept C29537977 @default.
• W2780234080 hasConcept C2994460389 @default.
• W2780234080 hasConcept C47170353 @default.
• W2780234080 hasConcept C502942594 @default.
• W2780234080 hasConcept C51551487 @default.
• W2780234080 hasConcept C54355233 @default.
• W2780234080 hasConcept C553184892 @default.
• W2780234080 hasConcept C55493867 @default.
• W2780234080 hasConcept C57074206 @default.
• W2780234080 hasConcept C62112901 @default.
• W2780234080 hasConcept C62478195 @default.
• W2780234080 hasConcept C71924100 @default.
• W2780234080 hasConcept C81885089 @default.
• W2780234080 hasConcept C86803240 @default.
• W2780234080 hasConcept C95444343 @default.
• W2780234080 hasConcept C96232424 @default.
• W2780234080 hasConcept C98274493 @default.
• W2780234080 hasConceptScore W2780234080C104317684 @default.
• W2780234080 hasConceptScore W2780234080C118995209 @default.
• W2780234080 hasConceptScore W2780234080C121608353 @default.
• W2780234080 hasConceptScore W2780234080C126322002 @default.
• W2780234080 hasConceptScore W2780234080C1491633281 @default.
• W2780234080 hasConceptScore W2780234080C153911025 @default.
• W2780234080 hasConceptScore W2780234080C178790620 @default.
• W2780234080 hasConceptScore W2780234080C185592680 @default.
• W2780234080 hasConceptScore W2780234080C190283241 @default.
• W2780234080 hasConceptScore W2780234080C2776415932 @default.
• W2780234080 hasConceptScore W2780234080C2776816829 @default.
• W2780234080 hasConceptScore W2780234080C2780783641 @default.
• W2780234080 hasConceptScore W2780234080C2781018059 @default.
• W2780234080 hasConceptScore W2780234080C2781323092 @default.

• next